Search

Displaying results 7311 - 7320 of 9314 in total
  1. Drug

    MK-8245

    go.drugbank.com/drugs/DB13024
    Investigational

    MK-8245 has been used in trials studying the treatment of Type 2 Diabetes Mellitus.

  2. Drug

    Urocortin-2

    go.drugbank.com/drugs/DB13033
    Investigational

    Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.

  3. Drug

    Gossypol

    go.drugbank.com/drugs/DB13044
    Investigational

    Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.

  4. Drug

    Pruvanserin

    go.drugbank.com/drugs/DB13094
    Investigational

    Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders.

  5. Drug

    FLX475

    go.drugbank.com/drugs/DB15570
    Investigational

    FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875]

  6. Drug

    AAV-CNGB3

    go.drugbank.com/drugs/DB18344
    Investigational

    AAV-CNGB3 is an adenovirus associated viral vector serotype 8 containing the human CNGB3 gene.

  7. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).

  8. Drug

    Inactivated SARS-CoV-2 Vaccine (Chinese Academy of Medical Sciences)

    go.drugbank.com/drugs/DB15863
    Experimental

    The SARS-CoV-2 Inactivated Vaccine is a purified vaccine that contains multiple antigens from the virus and is inactivated in Vero Cells[A219758]. … This vaccine specifically was developed in collaboration with the Chinese Academy of Medical Sciences, West China Second University Hospital, and Yunan Center for Disease Control and Prevention.

  9. Drug

    Tizaterkib

    go.drugbank.com/drugs/DB21296
    Investigational

    The usage of the INN stem '-terkib' in the name indicates that Tizaterkib is a extracellular signal-regulated kinase (ERK) inhibitor.

  10. Drug

    MVA3000

    go.drugbank.com/drugs/DB05040
    Experimental

    MVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of the immune system or